Showing 481 - 500 results of 1,886 for search '"insulin"', query time: 0.08s Refine Results
  1. 481
  2. 482
  3. 483
  4. 484
  5. 485
  6. 486
  7. 487
  8. 488
  9. 489

    Hospitalisation rates for epilepsy, asthma and insulin-dependent diabetes in 796 190 school-aged children and young people with and without intellectual disabilities: a record-linkage cohort study by Angela Henderson, Sally-Ann Cooper, Craig Melville, Michael Fleming, Gillian S Smith, Jill Pell, Deborah Cairns

    Published 2025-02-01
    “…Objectives To investigate hospitalisation rates for the ambulatory care-sensitive conditions of epilepsy, asthma and insulin-dependent diabetes in school-aged children and young people with intellectual disabilities in comparison with their peers.Design Record-linkage cohort study. …”
    Get full text
    Article
  10. 490

    Early applicability of retinopathy of prematurity score (ROPScore) and serum insulin growth factor-1 (IGF-1) for predicting treatment-requiring retinopathy of prematurity: a prospective cohort study by Aliaa Adel Ali, Nancy Abd El-Salam Ahmed Gomaa, Basma Samir Kamil, Ahmed Awadein, Heba Baz, Esraa Ahmed Elmazzahy

    Published 2025-01-01
    “…Objectives This study aimed to evaluate the accuracy of the retinopathy of prematurity score (ROPScore) and serum insulin-like growth factor-1 (IGF-1) for predicting treatment-requiring retinopathy of prematurity. …”
    Get full text
    Article
  11. 491

    A Novel Liposome Formulation Carrying Both an Insulin Peptide and a Ligand for Invariant Natural Killer T Cells Induces Accumulation of Regulatory T Cells to Islets in Nonobese Diabetic Mice by Hidetoshi Akimoto, Emi Fukuda-Kawaguchi, Omar Duramad, Yasuyuki Ishii, Kazunari Tanabe

    Published 2019-01-01
    “…These data indicate that the migration of insulin B-peptide-specific Tregs to islet of NOD mice that are involved in the suppression of pathogenic T cells related to diabetes onset and progression could be enhanced by the administration of liposomes containing α-GalCer and insulin B peptide.…”
    Get full text
    Article
  12. 492

    Interaction between Angiotensin II and Insulin/IGF-1 Exerted a Synergistic Stimulatory Effect on ERK1/2 Activation in Adrenocortical Carcinoma H295R Cells by An-li Tong, Fen Wang, Yun-ying Cui, Chun-yan Li, Yu-xiu Li

    Published 2016-01-01
    “…The cross talk between angiotensin II (Ang II) and insulin has been described mainly in cardiovascular cells, hepatocytes, adipocytes, and so forth, and to date no such cross talk was reported in adrenal. …”
    Get full text
    Article
  13. 493
  14. 494

    Swimming Exercise Alleviated Insulin Resistance by Regulating Tripartite Motif Family Protein 72 Expression and AKT Signal Pathway in Sprague-Dawley Rats Fed with High-Fat Diet by Jie Qi, Bo Yang, Cailing Ren, Jian Fu, Jun Zhang

    Published 2016-01-01
    “…We aimed to investigate whether swimming exercise could improve insulin resistance (IR) by regulating tripartite motif family protein 72 (TRIM72) expression and AKT signal pathway in rats fed with high-fat diet. …”
    Get full text
    Article
  15. 495
  16. 496

    Utilizing Technology-Enabled Intervention to Improve Blood Glucose Self-Management Outcome in Type 2 Diabetic Patients Initiated on Insulin Therapy: A Retrospective Real-World Study by Jian Lin, Xia Li, Shan Jiang, Xiao Ma, Yuxin Yang, Zhiguang Zhou

    Published 2020-01-01
    “…This retrospective study included T2DM patients who were initiated on insulin therapy (mostly premixed insulin) after failure to respond to oral antidiabetic drugs. …”
    Get full text
    Article
  17. 497
  18. 498

    SLC22A1 rs622342 Polymorphism Predicts Insulin Resistance Improvement in Patients with Type 2 Diabetes Mellitus Treated with Metformin: A Cross-Sectional Study by Kunrong Wu, Xiaoli Li, Yuedong Xu, Xiaoqian Zhang, Ziwan Guan, Shufang Zhang, Yan Li

    Published 2020-01-01
    “…The variant of rs622342 could be a predictor of insulin sensitivity in patients with T2DM treated with metformin. …”
    Get full text
    Article
  19. 499
  20. 500